Abstract:Abstract 4647 Introduction: Myelodysplastic syndromes (MDSs) comprise a heterogeneous group of stem cell disorders characterized by ineffective hematopoiesis presenting with peripheral cytopenias together with hyperplastic bone marrow.Patients with MDS show an increased but variable risk of progression to acute myeloid leukemia (AML).Although, cytogenetic abnormalities are known as a major role in pathogenetic mechanisms, only 30% to 50% of patients with de novo MDS have abnormal karyotype,An further understanding of the molecular pathogenesis of MDS is needed, however,littleis known about the genetic events and their potential value for predicting progression to AML. We aimed at studying the potential significance of IDH1,IDH2, JAK2V617F, NPM1, FLT3-ITD,c-KIT genes mutations in MDS and analyzed the interaction with other mutations in Chinese patients with MDS. Methods: We examined Chinese patients with de novo MDS for mutations in the IDH1,IDH2, JAK2, NPM1, FLT3-ITD,C-KIT genes.Female/male ratio was 39/49 and age ranged from 28.0–79.0 years (median, 58.0years).Genomic DNA was extracted from diagnostic marrow specimens,FLT3 internaltandem duplication(FLT3 –ITD) and JAK2V617F mutation was screened using polymerase chain reaction (PCR),c-KIT, NPM1 and IDH genes were assessed by PCR followed by direct sequencing, according to previously described protocols. Results: F Overall, in 7 patients (7.95%) IDH mutations were detected. None of them had IDH1 mutation,6 missense mutations (6.8%) in IDH2 (R140Q n=6) and 1 synonymous substitution (c.519G>A) in IDH2. Molecular genetic analysis of NPM1 and JAK2V617F revealed the presence of NPM1 exon 12 (2.27% 2/88) and JAK2V617F(3.4% 3/88 ) mutations. FLT3-ITD,c-KIT mutations in exon 8 and 17 were not detected at MDS stage and concurrent mutations were not found. 4 of 6 cases with IDH2 missense mutations presented normal karyotype. IDH2 mutations were restricted to 3 morphologic categories:refractory cytopenia with multilineage dysplasia (RCMD n=2),refractory anemia with excess blasts (RAEB-2 n=3) and refractory anemia with ringed sideroblasts(RARS n=1), Patients with IDH2 mutations were older (P 60years),but mutation status that is or not potentially useful for predicting progression to AML need further studying. Conclusions: FIDH2 mutations are frequent in Chinese patients with de vono MDS, and associated with older age, lower WBC count at diagnosis.JAK2V617F and NPM1 mutations are rare in MDS,but both of them correlated with morphologic categories.IDH1,c-KIT,FLT3-ITD were detected in our cohort,suggesting that these mutations may be not a key role in pathogenetic mechanisms of MDS. Disclosures: No relevant conflicts of interest to declare.

c-KIT and tyrosine kinase receptor FLT3 mutations in myelodysplastic syndrome

Clinical Significance of Cytogenetic and Molecular Genetic Abnormalities in 634 Chinese Patients with Myelodysplastic Syndromes

Expression and Function of the FLT3 Gene in Patients with Myelodysplastic Syndromes

FLT3 and NPM1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Normal Cytogenetics

Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia

TP53 Mutations Are Associated with Very Complex Karyotype and Suggest Poor Prognosis in Newly Diagnosed Myelodysplastic Syndrome Patients with Monosomal Karyotype.

[Karyotype Analysis of 283 Cases of Myelodysplastic Syndrome].

NPM1 and FLT3-ITD/TKD Gene Mutations in Acute Myeloid Leukemia

Combined Mutations of FLT3, IDH1,IDH2, JAK2, NPM1,c-KITgenes in Chinese Patients with Myelodysplastic Syndromes

Clinical Significance of C-KIT-D816V,NPM1 Gene Mutation in Acute Myloid Leukemia Patients

Expression of KDR Plus Detection of Flt3-ITD and NPM1 Mutation as a Prognostic Marker in AML Patients with Normal Karyotype.

[Fms-Like Tyrosine Kinase 3 Gene Mutations in Acute Myeloid Leukemia].

Mutation Analysis of 77 Patients with Normal-Karyotype Myelodysplastic Syndrome

Research of Gene Expression in Patients with Myelodysplastic Syndromes.

[C-Kit Mutation in Acute Myeloid Leukemia Patients with AML1-ETO Fusion Gene and Its Clinical Significance].

Gene Mutational Pattern and Expression Level in 560 Acute Myeloid Leukemia Patients and Their Clinical Relevance

FLT3 Gene Expression and Its Clinical Significance in Acute Myeloid Leukemia

Clinical and Molecular Characteristics of Megakaryocytes in Myelodysplastic Syndrome

[FLT3 Mutations in Children with Acute Myeloid Leukemia: a Single Center Study].

[TET2 and DLK1 Gene Expression and Their Clinical Significance in Bone Marrow CD(3)(+) T Cells of Patients with Myelodysplastic Syndrome].

Distinct mutation features and its clinical significance in myelodysplastic syndromes with normal karyotype